Chlamydia trachomatis inhibits apoptosis in infected cells by targeting the pro-apoptotic proteins Bax and Bak.


Journal

Cell death and differentiation
ISSN: 1476-5403
Titre abrégé: Cell Death Differ
Pays: England
ID NLM: 9437445

Informations de publication

Date de publication:
10 2022
Historique:
received: 19 05 2021
accepted: 24 03 2022
revised: 24 03 2022
pubmed: 11 4 2022
medline: 5 10 2022
entrez: 10 4 2022
Statut: ppublish

Résumé

Apoptosis acts in defense against microbial infection, and many infectious agents have developed strategies to inhibit host cell apoptosis. The human pathogen Chlamydia trachomatis (Ctr) is an obligate intracellular bacterium that strongly inhibits mitochondrial apoptosis of its human host cell but there is no agreement how the bacteria achieve this. We here provide a molecular analysis of chlamydial apoptosis-inhibition in infected human cells and demonstrate that the block of apoptosis occurs during the activation of the effectors of mitochondrial apoptosis, Bak and Bax. We use small-molecule Bcl-2-family inhibitors and gene targeting to show that previous models cannot explain the anti-apoptotic effect of chlamydial infection. Although the anti-apoptotic Bcl-2-family protein Mcl-1 was strongly upregulated upon infection, Mcl-1-deficient cells and cells where Mcl-1 was pharmacologically inactivated were still protected. Ctr-infection could inhibit both Bax- and Bak-induced apoptosis. Apoptotic Bax-oligomerization and association with the outer mitochondrial membrane was reduced upon chlamydial infection. Infection further inhibited apoptosis induced conformational changes of Bak, as evidenced by changes to protease sensitivity, oligomerization and release from the mitochondrial porin VDAC2. Mitochondria isolated from Ctr-infected cells were protected against the pro-apoptotic Bcl-2-family proteins Bim and tBid but this protection was lost upon protease digestion. However, the protective effect of Ctr-infection was reduced in cells lacking the Bax/Bak-regulator VDAC2. We further found that OmpA, a porin of the outer membrane of Ctr, associated upon experimental expression with mitochondria and inhibited apoptosis, phenocopying the effect of the infection. These results identify a novel way of apoptosis inhibition, involving only the most downstream modulator of mitochondrial apoptosis and suggest that Chlamydia has a protein dedicated to the inhibition of apoptosis to secure its survival in human cells.

Identifiants

pubmed: 35397654
doi: 10.1038/s41418-022-00995-0
pii: 10.1038/s41418-022-00995-0
pmc: PMC9525694
doi:

Substances chimiques

Apoptosis Regulatory Proteins 0
Myeloid Cell Leukemia Sequence 1 Protein 0
Proto-Oncogene Proteins c-bcl-2 0
bcl-2 Homologous Antagonist-Killer Protein 0
bcl-2-Associated X Protein 0
Peptide Hydrolases EC 3.4.-

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2046-2059

Informations de copyright

© 2022. The Author(s).

Références

Infect Immun. 2005 Mar;73(3):1861-4
pubmed: 15731089
Proc Natl Acad Sci U S A. 1995 May 23;92(11):4877-81
pubmed: 7761416
PLoS Pathog. 2006 May;2(5):e45
pubmed: 16710454
Nat Rev Microbiol. 2015 Oct;13(10):605-19
pubmed: 26373371
J Cell Biol. 2010 Jul 12;190(1):143-57
pubmed: 20624904
J Exp Med. 2004 Oct 4;200(7):905-16
pubmed: 15452181
Biochim Biophys Acta. 2016 Oct;1863(10):2503-14
pubmed: 27116927
Microbes Infect. 2008 Nov-Dec;10(14-15):1494-503
pubmed: 18832043
Nature. 2005 Jun 2;435(7042):677-81
pubmed: 15902208
Science. 2004 Apr 30;304(5671):728-30
pubmed: 15073324
Science. 1997 Feb 21;275(5303):1132-6
pubmed: 9027315
Sci Rep. 2016 Sep 13;6:32994
pubmed: 27620692
Nature. 2016 Oct 27;538(7626):477-482
pubmed: 27760111
Microbes Infect. 2006 May;8(6):1579-91
pubmed: 16698305
Pathog Dis. 2014 Aug;71(3):336-51
pubmed: 24838663
Cancer Cell. 2006 Nov;10(5):389-99
pubmed: 17097561
Mol Cell. 2009 Nov 25;36(4):696-703
pubmed: 19941828
EMBO Rep. 2016 May;17(5):724-38
pubmed: 27013495
Cell. 2011 Apr 1;145(1):104-16
pubmed: 21458670
Cell. 2008 Dec 12;135(6):1074-84
pubmed: 19062087
Sci Signal. 2009 Aug 25;2(85):ra48
pubmed: 19706873
PLoS Pathog. 2006 Oct;2(10):e114
pubmed: 17069460
J Infect Dis. 2008 Nov 15;198(10):1536-44
pubmed: 18821848
PLoS Pathog. 2018 Mar 30;14(3):e1006945
pubmed: 29601598
J Biol Chem. 2013 Sep 6;288(36):26027-26038
pubmed: 23893415
Cell. 2007 Apr 20;129(2):423-33
pubmed: 17448999
Proc Natl Acad Sci U S A. 2007 Jul 3;104(27):11430-5
pubmed: 17592133
Infect Immun. 2004 Feb;72(2):1107-15
pubmed: 14742558
J Exp Med. 1998 Feb 16;187(4):487-96
pubmed: 9463399
PLoS Pathog. 2015 Apr 23;11(4):e1004846
pubmed: 25906164
Mol Cell. 2011 Nov 18;44(4):517-31
pubmed: 22036586
Microbes Infect. 2018 Oct - Nov;20(9-10):552-559
pubmed: 29109017
Nat Commun. 2014 Nov 13;5:5201
pubmed: 25392082
J Bacteriol. 2018 Nov 26;200(24):
pubmed: 30297356
Mol Cell. 2010 Feb 12;37(3):299-310
pubmed: 20159550
EMBO J. 2019 Jun 3;38(11):
pubmed: 30979778
Cold Spring Harb Protoc. 2015 May 01;2015(5):472-6
pubmed: 25934937
Biochim Biophys Acta. 2010 Jun-Jul;1797(6-7):1292-9
pubmed: 20450883
J Cell Biol. 2017 Apr 3;216(4):1071-1089
pubmed: 28330939
PLoS One. 2008 Sep 01;3(9):e3102
pubmed: 18769617
FEBS J. 2018 Feb;285(3):416-431
pubmed: 28755482
J Biol Chem. 2010 Nov 19;285(47):36876-83
pubmed: 20851889
Cell Microbiol. 2010 Sep 1;12(9):1340-51
pubmed: 20482554
Mol Cell. 2008 May 9;30(3):369-80
pubmed: 18471982
Science. 2003 Jul 25;301(5632):513-7
pubmed: 12881569
Genes Dev. 2017 Sep 1;31(17):1754-1769
pubmed: 28982759
Nat Methods. 2014 Aug;11(8):783-784
pubmed: 25075903
PLoS Pathog. 2012;8(8):e1002842
pubmed: 22876181
PLoS Pathog. 2008 May 30;4(5):e1000018
pubmed: 18516228
Cell Death Differ. 2009 May;16(5):697-707
pubmed: 19165229
Infect Immun. 2001 Nov;69(11):7121-9
pubmed: 11598088
Methods Mol Biol. 2010;619:425-36
pubmed: 20419426
Curr Microbiol. 2011 Oct;63(4):341-6
pubmed: 21779937
Nat Commun. 2018 Nov 26;9(1):4976
pubmed: 30478310
J Infect. 2006 Dec;53(6):408-14
pubmed: 16490255
PLoS One. 2013 Dec 04;8(12):e80597
pubmed: 24324615
EBioMedicine. 2017 Sep;23:100-110
pubmed: 28803120
Curr Opin Microbiol. 2010 Feb;13(1):4-10
pubmed: 20006538
Curr Opin Struct Biol. 2011 Aug;21(4):523-31
pubmed: 21719274
Cell Death Differ. 2012 Aug;19(8):1328-36
pubmed: 22343714
Cell Death Differ. 2014 Dec;21(12):1925-35
pubmed: 25146925
Cell Microbiol. 2011 Oct;13(10):1573-85
pubmed: 21824245
Cell Microbiol. 2012 Jul;14(7):1010-8
pubmed: 22452394

Auteurs

Collins Waguia Kontchou (C)

Institute of Medical Microbiology and Hygiene, Medical Center - University of Freiburg, Faculty of Medicine, 79104, Freiburg, Germany.

Ian E Gentle (IE)

Institute of Medical Microbiology and Hygiene, Medical Center - University of Freiburg, Faculty of Medicine, 79104, Freiburg, Germany.

Arnim Weber (A)

Institute of Medical Microbiology and Hygiene, Medical Center - University of Freiburg, Faculty of Medicine, 79104, Freiburg, Germany.

Axel Schoeniger (A)

Veterinary Physiological Chemical Institute, Faculty of Veterinary Medicine, University of Leipzig, 04103, Leipzig, Germany.

Frank Edlich (F)

Veterinary Physiological Chemical Institute, Faculty of Veterinary Medicine, University of Leipzig, 04103, Leipzig, Germany.

Georg Häcker (G)

Institute of Medical Microbiology and Hygiene, Medical Center - University of Freiburg, Faculty of Medicine, 79104, Freiburg, Germany. georg.haecker@uniklinik-freiburg.de.
BIOSS Centre for Biological Signalling Studies, University of Freiburg, 79104, Freiburg, Germany. georg.haecker@uniklinik-freiburg.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH